G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -40.0% | 300 | -72.7% | 0.00% | – |
| Q2 2022 | $5,000 | -37.5% | 1,100 | -21.4% | 0.00% | – |
| Q1 2022 | $8,000 | -27.3% | 1,400 | +27.3% | 0.00% | – |
| Q4 2021 | $11,000 | -80.4% | 1,100 | -81.4% | 0.00% | -100.0% |
| Q3 2021 | $56,000 | 0.0% | 5,900 | -1.7% | 0.00% | +50.0% |
| Q2 2021 | $56,000 | -5.1% | 6,000 | +30.4% | 0.00% | 0.0% |
| Q1 2021 | $59,000 | +227.8% | 4,600 | +4.5% | 0.00% | +100.0% |
| Q4 2020 | $18,000 | 0.0% | 4,400 | -24.1% | 0.00% | 0.0% |
| Q3 2020 | $18,000 | -10.0% | 5,800 | +152.2% | 0.00% | 0.0% |
| Q2 2020 | $20,000 | +100.0% | 2,300 | -25.8% | 0.00% | – |
| Q1 2020 | $10,000 | -85.9% | 3,100 | +3.3% | 0.00% | -100.0% |
| Q4 2019 | $71,000 | +16.4% | 3,000 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $61,000 | +6000.0% | 3,000 | +2900.0% | 0.01% | – |
| Q1 2019 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
| DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
| XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
| Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
| ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |